SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,885.56 |
| Enterprise Value ($M) | 5,496.98 |
| Book Value ($M) | -1,054.35 |
| Book Value / Share | -13.67 |
| Price / Book | -3.69 |
| NCAV ($M) | -1,883.23 |
| NCAV / Share | -24.42 |
| Price / NCAV | -2.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.27 |
| Return on Assets (ROA) | -0.24 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.60 |
| Current Ratio | 1.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,013.36 |
| Assets | 1,842.24 |
| Liabilities | 2,896.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Camber Capital Management LP | |||
| 13G/A | Armistice Capital, Llc | |||
| 13G/A | Wellington Management Group Llp | |||
| 13G/A | State Street Corp | 3.80 | -37.44 | |
| 13G/A | Rtw Investments, Lp | 9.80 | 32.21 | |
| 13G/A | Vanguard Group Inc | 11.66 | 19.91 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 68,334 | 282,673 | 24.17 | |
| 63,427 | 407,933 | 15.55 | |
| 81,338 | 541,834 | 15.01 | |
| 101,750 | 635,461 | 16.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRAX – Praxis Precision Medicines, Inc. | PRLD – Prelude Therapeutics Incorporated |
| PRTA – Prothena Corporation plc | PYXS – Pyxis Oncology, Inc. |
| QDEL – QuidelOrtho Corporation |
Financial data and stock pages provided by
Fintel.io